CDH1 and Familial gastric cancer: These include, as essential innovations, the expansion of the screening criteria, the description of the above-mentioned HLBC entity (without the occurrence of gastric cancer in those affected) and the identification of the HDGC-like subgroup meeting the family screening criteria for HDGC, but with missing mutations in the CDH1 and CTNNA1 genes.